Alex Z. Fu

4.6k total citations · 1 hit paper
117 papers, 3.1k citations indexed

About

Alex Z. Fu is a scholar working on Economics and Econometrics, Hematology and Oncology. According to data from OpenAlex, Alex Z. Fu has authored 117 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Economics and Econometrics, 27 papers in Hematology and 20 papers in Oncology. Recurrent topics in Alex Z. Fu's work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Multiple Myeloma Research and Treatments (20 papers) and Diabetes Treatment and Management (12 papers). Alex Z. Fu is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (30 papers), Multiple Myeloma Research and Treatments (20 papers) and Diabetes Treatment and Management (12 papers). Alex Z. Fu collaborates with scholars based in United States, China and Canada. Alex Z. Fu's co-authors include Gordon G. Liu, Dale B. Christensen, Larry Radican, Michael W. Kattan, Ying Qiu, Kamlesh Khunti, Johan Bodegård, Reinhard W. Holl, Niklas Hammar and Peter Fenici and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Alex Z. Fu

106 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs

2017 604 citations Mikhail Kosiborod, Matthew A. Cavender et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alex Z. Fu United States	29	1.0k	566	504	480	347	117	3.1k
Colin R. Dormuth Canada	35	551 0.5×	1.2k 2.1×	763 1.5×	315 0.7×	390 1.1×	115	4.3k
Manel Pladevall United States	27	776 0.8×	258 0.5×	250 0.5×	234 0.5×	395 1.1×	57	3.4k
Sheldon X. Kong United States	29	567 0.6×	480 0.8×	637 1.3×	182 0.4×	265 0.8×	96	3.2k
Michael R. Gionfriddo United States	32	1.1k 1.1×	377 0.7×	652 1.3×	161 0.3×	1.1k 3.1×	108	4.0k
Kristina S. Boye United States	34	2.1k 2.1×	942 1.7×	396 0.8×	515 1.1×	415 1.2×	164	3.8k
Debra J. Jacobson United States	42	1.1k 1.0×	223 0.4×	569 1.1×	309 0.6×	414 1.2×	150	5.6k
Richard H. Chapman United States	32	488 0.5×	1.3k 2.4×	528 1.0×	197 0.4×	528 1.5×	69	3.9k
Jason Oke United Kingdom	23	580 0.6×	231 0.4×	470 0.9×	384 0.8×	373 1.1×	94	4.2k
Niels de Fine Olivarius Denmark	26	994 1.0×	309 0.5×	293 0.6×	223 0.5×	530 1.5×	96	3.0k
Diana Brixner United States	29	329 0.3×	497 0.9×	326 0.6×	187 0.4×	153 0.4×	174	2.7k

Countries citing papers authored by Alex Z. Fu

Since Specialization

Citations

This map shows the geographic impact of Alex Z. Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Z. Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Z. Fu more than expected).

Fields of papers citing papers by Alex Z. Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Z. Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Z. Fu. The network helps show where Alex Z. Fu may publish in the future.

Co-authorship network of co-authors of Alex Z. Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Z. Fu. A scholar is included among the top collaborators of Alex Z. Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Z. Fu. Alex Z. Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tachiki, Lisa, Daniel S. Hippe, Thomas H. Pulliam, et al.. (2025). Risk of disease progression after discontinuing immunotherapy in 105 patients with Merkel cell carcinoma who responded to PD-1 pathway blockade. Journal for ImmunoTherapy of Cancer. 13(8). e012123–e012123.

Akaike, Tomoko, Daniel S. Hippe, Matthew W. Gilmour, et al.. (2025). Merkel cell carcinoma in solid organ transplant recipients: prognosis and response to immunotherapy. British Journal of Dermatology. 193(6). 1221–1231.

Basu, Anirban, et al.. (2023). Real-world calibration and transportability of the Disease Recovery Evaluation and Modification (DREaM) randomized clinical trial in adult Medicaid beneficiaries with recent-onset schizophrenia. Journal of Managed Care & Specialty Pharmacy. 29(3). 293–302. 1 indexed citations

Mian, Hira, et al.. (2023). Real-World Treatment Patterns and Clinical Outcomes Among Triple-Class Exposed and B-Cell Maturation Antigen (BCMA) Exposed Multiple Myeloma Patients. Blood. 142(Supplement 1). 542–542.

Pesa, Jacqueline, et al.. (2023). Racial disparities in utilization of first-generation versus second-generation long-acting injectable antipsychotics in Medicaid beneficiaries with schizophrenia. Schizophrenia Research. 261. 170–177. 6 indexed citations

Fu, Alex Z., et al.. (2022). Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia. BMC Psychiatry. 22(1). 250–250. 17 indexed citations

Fu, Alex Z., et al.. (2021). How Well Have Practices Followed Guidelines in Prescribing Antihypertensive Drugs: The Role of Health Insurance. UNC Libraries.

Pesa, Jacqueline, et al.. (2021). PMU28 Association between Social Determinants of Health and Depression Among Patients with Psoriasis in the US. Value in Health. 24. S149–S149.

Ammann, Eric M., Annette Lam, Wenze Tang, et al.. (2020). Real-World Use of Maintenance Therapy and Associated Outcomes Following Autologous Stem Cell Transplant in US Patients with Newly Diagnosed Multiple Myeloma. Blood. 136(Supplement 1). 25–26. 1 indexed citations

10.

Casarin, Jvan, Chao Song, Francesco Multinu, et al.. (2019). Implementing robotic surgery for uterine cancer in the United States: Better outcomes without increased costs. Gynecologic Oncology. 156(2). 451–458. 35 indexed citations

11.

Zhang, Tiantian, Teng-Fei Lin, Lishun Liu, et al.. (2019). Health-related quality of life among rural men and women with hypertension: assessment by the EQ-5D-5L in Jiangsu, China. Quality of Life Research. 28(8). 2069–2080. 46 indexed citations

12.

Kosiborod, Mikhail, Matthew A. Cavender, Alex Z. Fu, et al.. (2017). Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs. Circulation. 136(3). 249–259. 604 indexed citations breakdown →

13.

Hao, Yanni, Alex Z. Fu, Ying Qiu, et al.. (2016). Clinical Outcomes Among Patients with Myelodysplastic Syndromes Treated with Iron Chelation Therapy: A Real World Medicare Database Study. Blood. 128(22). 2396–2396. 2 indexed citations

14.

Fu, Alex Z., Shawn X. Sun, Xingyue Huang, & Alpesh Amin. (2013). 30-Day Readmission Rate Associated With Roflumilast Treatment Among Patients Hospitalized for COPD. CHEST Journal. 144(4). 744A–744A. 1 indexed citations

15.

Allexandre, Didier, Emily Fox, Alex Z. Fu, et al.. (2013). Feasibility of an Online Mindfulness Program for Stress Management—A Randomized, Controlled Trial. Annals of Behavioral Medicine. 46(2). 137–148. 121 indexed citations

16.

Mazzone, Peter J., Nancy A. Obuchowski, Alex Z. Fu, Michael Phillips, & Moulay A. Meziane. (2013). Quality of Life and Healthcare Use in a Randomized Controlled Lung Cancer Screening Study. Annals of the American Thoracic Society. 10(4). 324–329. 20 indexed citations

17.

Fu, Alex Z., Yanping Qiu, Michael J. Davies, Larry Radican, & Samuel S. Engel. (2011). Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy. Diabetes Obesity and Metabolism. 13(8). 765–769. 68 indexed citations

18.

Hu, Bo & Alex Z. Fu. (2010). Predicting Utility for Joint Health States: A General Framework and a New Nonparametric Estimator. Medical Decision Making. 30(5). E29–E39. 36 indexed citations

19.

Fu, Alex Z., et al.. (2010). Effect of Medicare Part D on Potentially Inappropriate Medication Use by Older Adults. Journal of the American Geriatrics Society. 58(5). 944–949. 18 indexed citations

20.

Fu, Alex Z. & Liang Li. (2008). Thinking of having a higher predictive power for your first-stage model in propensity score analysis? Think again. Health Services and Outcomes Research Methodology. 8(2). 115–117. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact